This inventor holds 3 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: National Institute of Health and Medical Research, Centre National De La Recherche Scientifique, Bristol-Myers Squibb Compnay. Active years: 1997-2007.
Company Filing History:
3 out of 1,853 
2 out of 5,383 
1 out of 3,737 
Years Active: 1997-2007
Title: Yves Lutz: Innovator in Cancer Research
Introduction
Yves Lutz is a prominent inventor based in Strasbourg, France. He has made significant contributions to the field of cancer research, holding a total of 3 patents. His work focuses on innovative methods for diagnosing and treating cancer, showcasing his dedication to advancing medical science.
Latest Patents
Lutz's latest patents include groundbreaking inventions such as the ICBP90 polypeptide and its fragments, along with polynucleotides coding for these polypeptides. This invention is particularly relevant for diagnosing and treating cancer. It involves a novel ICBP90 (Inverted CCAAT box binding protein 90) and specific antibodies directed against these polypeptides. Additionally, he has developed methods and kits for diagnosing cell proliferation, as well as compounds useful in preventing and treating pathologies related to cell proliferation, especially cancer. Another significant patent is related to the transcriptional intermediary factor-2 (TIF2), which concerns a nuclear receptor transcriptional mediator. This invention provides isolated nucleic acid molecules encoding TIF2 and includes recombinant methods for producing TIF2 polypeptides and antibodies.
Career Highlights
Throughout his career, Yves Lutz has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. His experience in these institutions has allowed him to contribute to significant advancements in medical research.
Collaborations
Lutz has collaborated with notable colleagues, including Pierre H. Chambon and Cecile Rochette-Egly. These partnerships have further enriched his research and innovation in the field.
Conclusion
Yves Lutz stands out as an influential inventor in cancer research, with a focus on developing innovative solutions for diagnosis and treatment. His contributions continue to impact the medical field significantly.